Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 215

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 215
---
 does not intend to make any grants under the 2021 Plan.

The Board and stockholders
of the Company approved the 2023 Plan on October 4, 2023. Under the 2023 Plan, 4,012,785 shares of common stock were authorized for issuance
to employees, directors and independent contractors (except those performing services in connection with the offer or sale of the Company’s
securities in a capital raising transaction, or promoting or maintaining a market for the Company’s securities) of the Company or
its subsidiaries. As of March 28, 2025, there were 2,139,240 shares available for issuance under the 2023 Plan.

<div align='center'>SELLING STOCKHOLDER</div>

This prospectus relates to
the offer and sale by Yorkville, or the Selling Stockholder, of up to 10,000,000 shares of our common stock that have been and may
be issued by us to the Selling Stockholder under the SEPA. For additional information regarding the shares of our common stock included
in this prospectus, see the section titled “The Standby Equity Purchase Agreement” above. We are registering the shares
of our common stock included in this prospectus pursuant to the provisions of the Registration Rights Agreement we entered into with Yorkville
on October 24, 2025, in order to permit the Selling Stockholder to offer the shares included in this prospectus for resale from time to
time. Except for the transactions contemplated by the SEPA and the Registration Rights Agreement and as set forth in the section titled
“Plan of Distribution” in this prospectus, Yorkville has not had any material relationship with us within the past
three years. As used in this prospectus, the term “Selling Stockholder” means Yorkville.

The table below presents
information regarding the Selling Stockholder and the shares of our common stock that may be resold by the Selling Stockholder from time
to time under this prospectus. This table is prepared based on information supplied to us by the Selling Stockholder, and reflects holdings
as of November 25, 2025. The number of shares in the column “Maximum Number of Shares of Common Stock to be Offered Pursuant
to this Prospectus” represents all of the shares of our common stock being offered for resale by the Selling Stockholder under
this prospectus. The Selling Stockholder may sell some, all or none of the shares being offered for resale in this offering